160 related articles for article (PubMed ID: 14704397)
1. Disclosure and disinterest.
Kennedy D
Science; 2004 Jan; 303(5654):15. PubMed ID: 14704397
[No Abstract] [Full Text] [Related]
2. Science and regulation. A White House mandate for more peer review.
Kaiser J
Science; 2003 Sep; 301(5638):1307. PubMed ID: 12958338
[No Abstract] [Full Text] [Related]
3. Regulatory policy. White House softens disputed peer-review plan.
Kaiser J
Science; 2004 Apr; 304(5670):496-7. PubMed ID: 15105462
[No Abstract] [Full Text] [Related]
4. Questions about disclosure.
Henry CJ
Science; 2004 Jun; 304(5676):1447-9; author reply 1447-9. PubMed ID: 15178785
[No Abstract] [Full Text] [Related]
5. Science and government. Disclosure in regulatory science.
Michaels D; Wagner W
Science; 2003 Dec; 302(5653):2073. PubMed ID: 14684806
[No Abstract] [Full Text] [Related]
6. Editors and conflict of interest.
Baggs JG; Schmitt MH
Res Nurs Health; 2003 Apr; 26(2):87-9. PubMed ID: 12652605
[No Abstract] [Full Text] [Related]
7. Virus.
Bazell R
New Repub; 1992 Nov; 207(20):21-2. PubMed ID: 11659543
[No Abstract] [Full Text] [Related]
8. Peer review and federal regulations.
Steinbrook R
N Engl J Med; 2004 Jan; 350(2):103-4. PubMed ID: 14711908
[No Abstract] [Full Text] [Related]
9. Full disclosure of financial interests in biomedical publications--a reminder.
Bailey BJ
Laryngoscope; 2002 Feb; 112(2):211-2. PubMed ID: 11889370
[No Abstract] [Full Text] [Related]
10. Grants management. NSF survey of applicants finds a system teetering on the brink.
Mervis J
Science; 2007 Aug; 317(5840):880-1. PubMed ID: 17702914
[No Abstract] [Full Text] [Related]
11. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
Saver RS
William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
[No Abstract] [Full Text] [Related]
12. Declaration of financial interests.
Nat Cell Biol; 2001 Oct; 3(10):E219-20. PubMed ID: 11584279
[No Abstract] [Full Text] [Related]
13. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
Jordan KA
Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
[No Abstract] [Full Text] [Related]
14. The search for a cure: combating the problem of conflicts of interest that currently plagues biomedical research.
Clamon JB
Iowa Law Rev; 2003 Oct; 89(1):235-71. PubMed ID: 15732180
[No Abstract] [Full Text] [Related]
15. Praise, for a change.
Kennedy D
Science; 2004 May; 304(5674):1077. PubMed ID: 15155914
[No Abstract] [Full Text] [Related]
16. National Institutes of Health enacts final ethics regulations.
Ness AC
J Biolaw Bus; 2006; 9(1):50-1. PubMed ID: 17111527
[TBL] [Abstract][Full Text] [Related]
17. Authors, industry, and review articles.
DeMaria AN
J Am Coll Cardiol; 2004 Mar; 43(6):1130-1. PubMed ID: 15028380
[No Abstract] [Full Text] [Related]
18. Survey of conflict-of-interest disclosure policies of ophthalmology journals.
Anraku A; Jin YP; Trope GE; Buys YM
Ophthalmology; 2009 Jun; 116(6):1093-6. PubMed ID: 19376583
[TBL] [Abstract][Full Text] [Related]
19. Scholarly publishing. U.S. eases the squeeze on 'sanctioned' authors.
Bhattacharjee Y
Science; 2004 Apr; 304(5668):187. PubMed ID: 15073341
[No Abstract] [Full Text] [Related]
20. Financial conflicts of interest in biomedical human subject research.
Goldstein N
J Biolaw Bus; 2006; 9(1):26-37. PubMed ID: 17111525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]